Dual targeting of EGFR and HER-2 in colon cancer cell lines

被引：0
|
作者：
Efstathia Giannopoulou
Anna Antonacopoulou
Konstantina Floratou
Athanasios G. Papavassiliou
Haralabos P. Kalofonos
机构：
[1] University Hospital of Patras,Clinical Oncology Laboratory, Division of Oncology, Department of Medicine
[2] Patras Medical School,Department of Biological Chemistry, Medical School
[3] University of Athens,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2009年 / 63卷
关键词：
Gefitinib; Lapatinib; Trastuzumab; Caco-2; DLD-1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：973 / 981
页数：8
相关论文
共 50 条
  • [21] Monoclonal antibody to HER-2/neu receptor enhances radiosensitivity of esophageal cancer cell lines expressing HER-2/neu oncoprotein
    Sato, S
    Kajiyama, Y
    Sugano, M
    Iwanuma, Y
    Sonoue, H
    Matsumoto, T
    Sasai, K
    Tsurumaru, M
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (01): : 203 - 211
  • [22] The effect of a dimeric Affibody molecule (ZEGFR:1907)2 targeting EGFR in combination with radiation in colon cancer cell lines
    Sahlberg, Sara Haggblad
    Spiegelberg, Diana
    Lennartsson, Johan
    Nygren, Peter
    Glimelius, Bengt
    Stenerlow, Bo
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 40 (01) : 176 - 184
  • [23] Sensitivity of EGFR/HER-2 Positive Cells Isolated from Ascitic Fluid of Advanced Ovarian Cancer Patients to EGFR/HER-2 Inhibitors
    Chitcholtan, Kenny
    Harker, Dianne
    Simcock, Bryony
    Sykes, Peter
    APPLIED SCIENCES-BASEL, 2020, 10 (07):
  • [24] Combined molecular targeted drug therapy for EGFR and HER-2 in head and neck squamous cell carcinoma cell lines
    Kondo, Norio
    Tsukuda, Mamoru
    Sakakibara, Atsuko
    Takahashi, Hideaki
    Hyakusoku, Hiroshi
    Komatsu, Masanori
    Niho, Tatsuo
    Nakazaki, Kouich
    Toth, Gabor
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 40 (06) : 1805 - 1812
  • [25] Expression of the epidermal growth factor receptors (EGFR and HER-2) in esophageal squamous cell cancer
    Delektorskaya, V. V.
    Jurievna, Chemeris G.
    Kononec, V. P.
    Grigorchuk, Ju. A.
    VIRCHOWS ARCHIV, 2009, 455 : 137 - 137
  • [26] The dual EGFR/HER-2 tyrosine kinase inhibitor lapatinib sensitizes colon and gastric cancer cells to the irinotecan active metabolite SN-38
    LaBonte, Melissa J.
    Manegold, Philipp C.
    Wilson, Peter M.
    Fazzone, Will
    Louie, Stan G.
    Lenz, Heinz-Josef
    Ladner, Robert D.
    INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (12) : 2957 - 2969
  • [27] FATE OF MABS TO HER-2 RECEPTOR IN BREAST-CANCER CELL-LINES
    LI, W
    KELLER, GA
    MOLECULAR BIOLOGY OF THE CELL, 1992, 3 : A24 - A24
  • [28] HER-2 stimulates the EGFR via a ligand-dependent process in colon cells
    Kuwada, SK
    Kuang, JQ
    Li, XF
    Wong, R
    GASTROENTEROLOGY, 2003, 124 (04) : A282 - A282
  • [29] Targeting EGFR and HER-2 with cetuximab- and trastuzumab-mediated immunotherapy in oesophageal squamous cell carcinoma
    Y Kawaguchi
    K Kono
    K Mimura
    F Mitsui
    H Sugai
    H Akaike
    H Fujii
    British Journal of Cancer, 2007, 97 : 494 - 501
  • [30] Targeting EGFR and HER-2 with cetuximab- and trastuzumab-mediated immunotherapy in oesophageal squamous cell carcinoma
    Kawaguchi, Y.
    Kono, K.
    Mimura, K.
    Mitsui, F.
    Sugai, H.
    Akaike, H.
    Fujii, H.
    BRITISH JOURNAL OF CANCER, 2007, 97 (04) : 494 - 501
12345